ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S.
The Dispatch–Argus19h
Woodworker, Davenport officer help pull off surprise for woman who fell victim to scam
When Davenport police corporal Dave Morse took a report of a woman being scammed out of thousands of dollars for a custom ...